Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)

Clinical trial NCT01376154 · COMPLETED

Trial details

NCT number: NCT01376154
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatitis B, Chronic

Start date: 2006-06-01
Primary completion: 2009-12-01
Enrollment: 342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.